SCHEMBL5439724

SCHEMBL5439724

CC[C@@H]1C(C)=NN=C(c2ccc(OC)c(OC)c2)c2cc(O)c(O)cc21

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.82
MEN1 O00255 5/20 0.82
CHRM1 P11229 1/20 0.82
PDE4A P27815 1/20 0.82
PDE4D Q08499 1/20 0.82
PDE3A Q14432 1/20 0.82
HSP90AA1 P07900 1/20 0.39
TSHR P16473 2/20 0.39
LMNA P02545 4/20 0.37
ALDH1A1 P00352 4/20 0.37
POLB P06746 3/20 0.37
ALOX12 P18054 4/20 0.36
NPC1 O15118 3/20 0.36
HSD17B10 Q99714 3/20 0.36
HPGD P15428 1/20 0.36
MAPT P10636 4/20 0.36
KDM4E B2RXH2 3/20 0.36
MAPK1 P28482 2/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5431967 1.00 KMT2A (0.82) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL5426502 0.94 MEN1 (0.84) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL3242127 0.94 MEN1 (0.84) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL3236700 0.94 MEN1 (0.84) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL3242116 0.94 MEN1 (0.84) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL4307435 0.94 MEN1 (0.84) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL13293822 0.94 MEN1 (0.84) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL13293821 0.94 MEN1 (0.84) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL3244539 0.94 MEN1 (0.84) KMT2AMEN1CHRM1PDE4APDE4D
SCHEMBL7432334 0.93 MEN1 (0.70) KMT2AMEN1CHRM1PDE4APDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070161628-A1 Phosphodiesterase inhibitors GREENPHARMA (FR) 2007-07-12 US claimed
US-20070161628-A1 Phosphodiesterase inhibitors GREENPHARMA (FR) 2007-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161628-A1 Phosphodiesterase inhibitors PDE5A, PDE3A, PDE3B KMT2A 2209/4885MEN1 3432/4885CHRM1 395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.